Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$473K Buy
2,106
+567
+37% +$141K 0.07% 247
2025
Q4
$371K Sell
1,539
-102
-6% -$26.1K 0.05% 285
2025
Q3
$449K Buy
1,641
+89
+6% +$24.3K 0.06% 239
2025
Q2
$400K Sell
1,552
-228
-13% -$54.4K 0.06% 239
2025
Q1
$398K Sell
1,780
-784
-31% -$183K 0.03% 236
2024
Q4
$586K Sell
2,564
-161
-6% -$38.8K 0.03% 173
2024
Q3
$665K Sell
2,725
-84
-3% -$18.8K 0.04% 163
2024
Q2
$538K Buy
2,809
+44
+2% +$8.93K 0.03% 193
2024
Q1
$548K Hold
2,765
0.03% 180
2023
Q4
$476K Buy
2,765
+690
+33% +$106K 0.03% 189
2023
Q3
$307K Buy
+2,075
New +$375K 0.02% 259
2023
Q2
Sell
-854
Closed -$187K 1351
2023
Q1
$187K Buy
854
+177
+26% +$38.4K 0.01% 330
2022
Q4
$141K Sell
677
-273
-29% -$60K 0.01% 365
2022
Q3
$207K Buy
950
+234
+33% +$53.3K 0.02% 267
2022
Q2
$150K Sell
716
-509
-42% -$108K 0.01% 340
2022
Q1
$297K Buy
1,225
+721
+143% +$174K 0.03% 241
2021
Q4
$131K Buy
504
+125
+33% +$32.4K 0.01% 354
2021
Q3
$100K Sell
379
-27
-7% -$7.38K 0.01% 379
2021
Q2
$100K Buy
406
+28
+7% +$5.89K 0.01% 368
2021
Q1
$73K Sell
378
-43
-10% -$8.62K 0.01% 393
2020
Q4
$89K Buy
421
+138
+49% +$27.5K 0.01% 334
2020
Q3
$49K Buy
283
+68
+32% +$12.6K 0.01% 378
2020
Q2
$41K Buy
215
+45
+26% +$7.36K 0.01% 389
2020
Q1
$25K Hold
170
0.01% 390
2019
Q4
$26K Buy
170
+164
+2,733% +$23.6K 0.01% 364
2019
Q3
$1K Hold
6
﹤0.01% 450
2019
Q2
$1K Sell
6
-6
-50% -$665 ﹤0.01% 374
2019
Q1
$1K Hold
12
﹤0.01% 325
2018
Q4
$1K Buy
+12
New +$1.29K ﹤0.01% 487

Other funds holding RMD

Ellevest Inc's RMD Position: Q1 2026 in Review

Ellevest Inc increased its ResMed (RMD) stake by 37% in Q1 2026, buying an estimated $141K and bringing the position to 2,106 shares worth $473K. The position accounts for 0.07% of the portfolio, ranked #247.

Ellevest Inc first reported a position in RMD in Q4 2018 and has held it in 29 quarters since. The position peaked at $665K in Q3 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Ellevest Inc held 2,106 shares of ResMed worth $473K as of Q1 2026.
  • Ellevest Inc bought 567 ResMed shares in Q1 2026, an estimated $141K.
  • ResMed made up 0.07% of Ellevest Inc's portfolio in Q1 2026, its #247 holding.
  • Ellevest Inc first reported a position in ResMed in Q4 2018 and has held it in 29 quarters since.
  • Ellevest Inc's ResMed position peaked at $665K in Q3 2024.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Ellevest Inc's 13F filing for Q1 2026, filed 11 May 2026.